Johnson & Johnson (JNJ)

Add to Watchlists
Create an Alert
101.35 -1.07  -1.04% NYSE May 22, 8:00PM Delayed 2m USD

Johnson & Johnson Research and Development Expense (Quarterly):

1.899B for March 31, 2015

View 4,000+ financial data types

View Full Chart

Johnson & Johnson Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Johnson & Johnson Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2015 1.899B
Dec. 31, 2014 2.791B
Sept. 30, 2014 2.023B
June 30, 2014 2.005B
March 31, 2014 1.831B
Dec. 31, 2013 2.749B
Sept. 30, 2013 2.22B
June 30, 2013 1.946B
March 31, 2013 1.784B
Dec. 31, 2012 2.331B
Sept. 30, 2012 1.923B
June 30, 2012 1.766B
March 31, 2012 1.645B
Dec. 31, 2011 2.155B
Sept. 30, 2011 1.773B
June 30, 2011 1.882B
March 31, 2011 1.738B
Dec. 31, 2010 1.982B
Sept. 30, 2010 1.657B
June 30, 2010 1.648B
March 31, 2010 1.557B
Dec. 31, 2009 2.213B
Sept. 30, 2009 1.617B
June 30, 2009 1.638B
March 31, 2009 1.518B
Dec. 31, 2008 2.108B
Sept. 30, 2008 1.861B
June 30, 2008 1.936B
March 31, 2008 1.712B
Dec. 31, 2007 2.328B
Sept. 30, 2007 1.834B
June 30, 2007 1.866B
March 31, 2007 1.652B
Dec. 31, 2006 2.046B
Sept. 30, 2006 1.719B
June 30, 2006 1.828B
March 31, 2006 1.532B
Dec. 31, 2005 2.014B
Sept. 30, 2005 1.539B
June 30, 2005 1.525B
March 31, 2005 1.384B
Dec. 31, 2004 1.868B
Sept. 30, 2004 1.198B
June 30, 2004 1.182B
March 31, 2004 1.095B
Dec. 31, 2003 1.489B
Sept. 30, 2003 1.177B
June 30, 2003 1.082B
March 31, 2003 936.00M
Dec. 31, 2002 1.242B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


JNJ Research and Development Expense (Quarterly) Benchmarks

AbbVie 938.00M
Sanofi 1.353B
Pfizer 1.885B

JNJ Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.645B Mar 2012
Maximum 2.791B Dec 2014
Average 1.987B

JNJ Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("JNJ", "r_and_d_expense")
  • Last 5 data points: =YCS("JNJ", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.